Skip to main content
Ying Xian, MD, Radiology, Houston, TX

Ying Xian MD


Resident Physician at Houston Methodist

Join to View Full Profile
  • 6565 Fannin StHouston, TX 77030

Dr. Xian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineResidency, Radiology-Diagnostic, 2018 - 2019
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2018, M.D.
  • California Institute of Technology
    California Institute of TechnologyB.S., Chemistry, English, Honors, 2009 - 2013

Publications & Presentations

Journal Articles

  • Trends in Reperfusion Therapy for in-Hospital Ischemic Stroke in the Endovascular Therapy Era  
    Feras Akbik, Ying Xian, Eric E Smith, Deepak L Bhatt, Gregg C Fonarow, Lee H Schwamm, JAMA Neurology

Abstracts/Posters

  • Clinicopathologic Analysis of Renal Cell Carcinoma Containing Intratumoral Fat and Osseous Metaplasia.
    Xian Z, Orien JO, Box GN, Zynger DL, North Central Section of the American Urology Association Annual Meeting, Chicago, IL, 9/2018
  • Pathologist’s Practice Patterns in Breast Cancer Biomarker Testing After Neoadjuvant Chemotherapy.
    Xian Z, Quinones AK, Tozbikian G, Zynger DL, American Society for Clinical Pathology Annual Meeting, Chicago, IL, 9/2017
  • Do Tumor Characteristics Predict Changes in Breast Cancer Biomarkers Following Neoadjuvant Chemotherapy?
    Xian Z, Quinones AK, Tozbikian G, Zynger DL, United States and Canadian Academy of Pathology, San Antonio, TX, 3/2017

Press Mentions

  • Duke Neurology Research Round up, May 2021
    Duke Neurology Research Round up, May 2021May 3rd, 2021
  • Clinical Characteristics and Outcomes Associated with Oral Anticoagulant Use Among Patients Hospitalized with Intracerebral Hemorrhage
    Clinical Characteristics and Outcomes Associated with Oral Anticoagulant Use Among Patients Hospitalized with Intracerebral HemorrhageFebruary 1st, 2021
  • Warfarin Use Should Not Disqualify Stroke Patients from Lifesaving Clot-Removing Surgery
    Warfarin Use Should Not Disqualify Stroke Patients from Lifesaving Clot-Removing SurgeryJune 27th, 2023
  • Join now to see all

Grant Support

  • Post-stroke Cognitive Impairment and DementiaUT SOUTHWESTERN MEDICAL CENTER2024–2029
  • Post-stroke Cognitive Impairment and DementiaUT SOUTHWESTERN MEDICAL CENTER2024–2029
  • Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial FibrillationUT SOUTHWESTERN MEDICAL CENTER2020–2026
  • Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial FibrillationUT SOUTHWESTERN MEDICAL CENTER2020–2026
  • Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)UT SOUTHWESTERN MEDICAL CENTER2019–2025

Other Languages

  • Chinese (Mandarin)

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: